Articles tagged "Vaccination"

2022 American Transplant Congress
Kinetics and Durability of a Third Dose of Sars-cov-2 Vaccination Among Solid Organ Transplant Recipients
T. P. Chiang, J. Alejo, J. Mitchell, A. Abedon, L. Zeizer, J. Kim, L. Thomas, D. Segev, W. Werbel, A. Massie
Johns Hopkins University, Baltimore, MD
*Purpose: Understanding the dynamics of antibody response to a third dose (D3) of anti-SARS-CoV-2 vaccine in solid organ transplant recipients (SOTRs) is important to inform…
2022 American Transplant Congress
Impact of Pretransplant Infectious Diseases Wellness Visit on Vaccine Uptake in Solid Organ Transplant Candidates
J. Jarrah, Z. Hanna, J. Williams, J. McCorquodale, T. Párraga, S. Greenlee, O. Abreu Lanfranco, M. Ramesh, R. del Busto, G. Alangaden
Transplant Infectious Diseases, Henry Ford Hospital, Detroit, MI
*Purpose: Vaccination rates in solid organ transplant candidates (SOTc) remains suboptimal. We report the effect of a dedicated Infectious Disease Pre-transplant (IDPT) clinic visit on…
2022 American Transplant Congress
Differences in Strength and Longevity of SARS-CoV-2-Specific Adaptive Immunity Between Convalescent and Vaccinated SOT Patients and Immunocompetent Individuals
L. Donadeu¹, S. Gomez¹, A. Fava'², E. Crespo¹, F. Moreso³, M. Lopez³, L. Lladó⁴, J. González⁴, I. Campos³, M. Muñoz³, J. Quintero³, J. Esperalba³, O. Bestard³
¹Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, ²Bellvitge University Hospital, L'Hospitalet de Llobregat. Barcelona, Spain, ³Vall d’Hebron University Hospital (HUVH), Barcelona, Spain, ⁴Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain
*Purpose: Short-term adaptive immune memory has been reported among immunocompetent (IC) and convalescent Solid Organ Transplant (SOT) individuals following SARS-CoV-2 infection as well as after…
2022 American Transplant Congress
Benefits of Inactivated Vaccine and Viral Vector Vaccine Immunization on Covid-19 Infection in Kidney Transplant Recipients
N. Sutharattanapong, S. Thotsiri, S. Kantachuvesiri, P. Wiwattanathum
Excellent Center of Organ Transplantation, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
*Purpose: Most developing countries do not have access to high-efficiency mRNA vaccine. In Thailand, the first and most available vaccines were inactivated, and later on,…
2022 American Transplant Congress
Utilization of a Pharmacy Technician to Improve Immunization Rates for Pediatric Heart and Kidney Transplant Recipients
A. Brewer¹, E. Benefield¹, S. Boehme¹, B. Jensen¹, K. Molina², C. Peterson², C. Heyrend¹
¹Primary Children's Hospital, Salt Lake City, UT, ²University of Utah, Salt Lake City, UT
*Purpose: Transplant recipients are at increased risk of infectious complications from vaccine-preventable diseases. This study aimed to evaluate using a pharmacy technician to provide routine…
2022 American Transplant Congress
Covid19 in Pediatric Kidney Transplant Recipients: Incidence, Outcomes, and Response to Vaccine
A. Moudgil, K. Sgambat, Y. Shi, M. Meyers, C. Petyak, L. Midgley
Nephrology, Children's National Med. Ctr., Washington, DC
*Purpose: At the onset of pandemic, no information was available on response of pediatric kidney transplant (PKTX) recipients to COVID19. When COVID19 vaccines became available,…
2022 American Transplant Congress
Sirolimus Use Is Associated With An Improved Immune Response To Covid-19 Vaccination In Kidney Transplant Recipients
G. B. Perkins¹, M. Tunbridge², T. Salehi², C. Chai¹, C. M. Hope¹, P. Garcia-Valtanen¹, J. J. Singer³, P. R. Hurtado², S. C. Barry¹, B. Grubor-Bauk¹, P. Hissaria², S. J. Chadban³, P. Coates¹
¹University of Adelaide, Adelaide, Australia, ²Royal Adelaide Hospital, Adelaide, Australia, ³Royal Prince Alfred Hospital, Sydney, Australia
*Purpose: Kidney transplant recipients (KTRs) are highly vulnerable to severe COVID-19, however are poorly protected by vaccination. Additional vaccine doses have achieved limited improvements in…
2022 American Transplant Congress
Sars-cov2 Antibody Kinetics and Durability Three and Six Months After Two-Doses of MRNA Vaccination in Liver Transplant Recipients
A. Chang¹, A. T. Strauss¹, T. P. Chiang¹, A. Jennifer¹, H. Nicole¹, L. Zeiser¹, B. Boyarsky¹, R. Avery¹, A. Tobian¹, M. Levan¹, D. Warren¹, A. Massie¹, J. Garonzik-Wang², D. Segev¹, W. Werbel¹
¹Johns Hopkins University School of Medicine, Baltimore, MD, ²University of Wisconsin School of Medicine, Madison, WI
*Purpose: nti-spike antibody response to SARS-CoV-2 vaccination is diminished in LT recipients compared to the general population so understanding durability for those that do respond…
2022 American Transplant Congress
Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in Pediatric Kidney and Liver Transplant Recipients
T. Kitano¹, K. Schwartz², M. Abdulnoor¹, H. Garfield³, N. K. Booran¹, Y. Avitzur¹, C. Teoh¹, D. Hebert⁴, U. Allen³
¹Hospital for Sick Children, Toronto, ON, Canada, ²Public Health Ontario, Toronto, ON, Canada, ³University of Toronto, Toronto, ON, Canada, ⁴The Hospital for Sick Children, Toronto, ON, Canada
*Purpose: Solid-organ transplant recipients are at increased risk of developing human papillomavirus (HPV)-related diseases. The immunogenicity of HPV vaccine for solid-organ transplant population needs further…
2022 American Transplant Congress
Pre-Transplant Vaccine Induced SARS-CoV-2 Antibodies Decrease Following Induction Therapy for Kidney Transplantation
N. Barros¹, A. C. Ermel¹, A. Sharfuddin², W. Goggins³, J. Fridell²
¹Indiana University, Indianapolis, IN, ²Indiana University School of Medicine, Indianapolis, IN, ³Indiana University Hospital, Indianapolis, IN
*Purpose: Kidney transplant recipients (KT) and wait-listed individuals exhibit an impaired response to vaccinations. There is currently no data on the impact of induction immunosuppression…

1
2
3
…
18
Next Page »